Escitalopram (Lexapro) for Depression

Masilamani, Santhi; Ruppelt, Sara C.
December 2003
American Family Physician;12/1/2003, Vol. 68 Issue 11, p2235
Academic Journal
Evaluates the drug escitalopram, used to treat major depressive disorder. Safety; Tolerability; Effectiveness; Mechanism of action.


Related Articles

  • A guide to switching antidepressant therapy. Ferentz, Kevin Scott // Patient Care;Jan2007, Vol. 41 Issue 1, p16 

    The article discusses the Sequenced Treatment Alternatives to Relieve Depression study funded by the National Institutes of Health's National Institute of Mental Health (NIMH) in the U.S. The study is designed to examine the effectiveness of different treatment strategies for those who did not...

  • Review: Low dose was as effective as standard dose tricyclic antidepressants in adults with depression. Simon, Gregory E. // ACP Journal Club;Mar/Apr2003, Vol. 138 Issue 2, p52 

    Compares the effectiveness of low-dose with standard-dose tricyclic antidepressants in patients having acute-phase treatment for depression. Details of the randomized controlled trials used in the study; Aspects of tricyclic antidepressants; Reason that the Depression and Bipolar Support...

  • COMMENTARIES. Craft, Lynette L. // International Journal of Therapy & Rehabilitation;Oct2008, Vol. 15 Issue 10, p464 

    The author reflects on the effects of clinical depression on mental and physical health. She argues that traditional treatment such as psychotherapy and medication are expensive and can have negative side-effects. She suggests that there should be advances and development in antidepressant...

  • Clozapine in the treatment of psychotic refractory depression. Dassa, Daniel; Kaladjian, Arthur; Azorin, Jean M.; Giudicelli, Sebastien; Dassa, D; Kaladjian, A; Azorin, J M; Giudicelli, S // British Journal of Psychiatry;Dec93, Vol. 163, p822 

    A 40-year-old woman suffering from major depression with psychotic features was unresponsive to conventional therapy. After the administration of a wide range of drug treatments and ECT, she received clozapine. Depressive symptoms improved and psychotic features disappeared. It is suggested that...

  • Benefits of bright light in non-seasonal major depression not sustained after discontinuation. Martiny, K.; Lunde, M.; Unden, M. // Evidence Based Mental Health;May2007, Vol. 10 Issue 2, p49 

    The article presents information on a research that analyzed the efficacy of bright light therapy in the treatment of major depression. For this study, patients suffering from depression were given bright and dim light treatment. The research showed an improvement in the rate of response and...

  • Contents of General Practitioner-Patient Consultations in the Treatment of Depression. Linden, Michael; Christof, Tatjana; Rentzsch, Christiane // JGIM: Journal of General Internal Medicine;Oct2008, Vol. 23 Issue 10, p1567 

    Counseling of patients is an indispensable part of any drug treatment and even more so in the treatment of depression. To describe the content of counseling additional to prescribing an antidepressant drug. Sixty-three general practices from all over Germany. Three hundred two patients with the...

  • Bupropion HCL and Sleep in Patients with Depression. Krystal, Andrew D.; Thase, Michael E.; Tucker, Vivian L.; Goodale, Elizabeth P. // Current Psychiatry Reviews;2007, Vol. 3 Issue 2, p123 

    Objectives: Depressed patients often have insomnia, daytime sleepiness, and/or changes in sleep architecture. These sleep/wake changes are associated with diminished quality of life, impaired function, diminished treatment response and greater risk of relapse. Antidepressants may cause,...

  • Discontinuation Syndrome Associated with Paroxetine in Depressed Patients: A Retrospective Analysis of Factors Involved in the Occurrence of the Syndrome. Himei, Akio; Okamura, Takehiko // CNS Drugs;2006, Vol. 20 Issue 8, p665 

    OBJECTIVE: To examine the factors that contribute to the occurrence of the discontinuation syndrome in patients who have received paroxetine to treat depression. METHOD: The clinical records of individuals from the outpatient units of two centres in the western area of Japan who had had a...

  • Remission from depression : a review of venlafaxine clinical and economic evidence. Han, Donald; Wang, Edward C.Y. // PharmacoEconomics;2005, Vol. 23 Issue 6, p567 

    Worldwide, major depression is the leading cause of years lived with a disability, and the fourth cause of disability-adjusted life years. Depression is second only to hypertension as the most common chronic condition encountered in general medical practice. Unfortunately, despite the high...

  • Prescribing for depression. Newson, Louise // GP: General Practitioner;4/21/2006, p50 

    The article focuses on the treatment of depression. Depression is considered to be a common and debilitating condition. According to meta-analysis, Selective Serotonin Reuptake Inhibitors (SSRIs) and low-dose tricyclic antidepressants are effective in treating depression in primary care. This is...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics